Pancreatic Ductal Adenocarcinoma Active Not Recruiting Phase 3 Trials for Fluorouracil (DB00544)

IndicationStatusPhase
DBCOND0034446 (Pancreatic Ductal Adenocarcinoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01013649Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryTreatment